Clinical Research Directory
Browse clinical research sites, groups, and studies.
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
Sponsor: Melbourne Health
Summary
The purpose of the study is to investigate the pharmacokinetics of oral dosage of Posaconazole which is routinely administered as a standard care prophylaxis for patients undergoing cancer treatments.
Official title: Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2019-08-01
Completion Date
2025-12-30
Last Updated
2025-02-28
Healthy Volunteers
No
Conditions
Interventions
Posaconazole pharmacokinetics
Blood samples will be collected on Days 7, 14 and 21 from the onset of Posaconazole prophylactic treatment If significant diarrhoea occurs, additional blood samples will be collected twice weekly until symptoms resolve. All blood samples will be used for Posaconazole pharmacokinetics study.
Locations (1)
Melbourne Health
Parkville, Victoria, Australia